ERBB2 and breast carcinoma: To evaluate the prognostic potential of UAB36 against the established gene signatures ENDORSE and PAM50, we performed Cox regression analysis for overall survival in the METABRIC ER+/HER2- breast cancer cohort treated with tamoxifen.